Stock LAB STANDARD BIOTOOLS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Standard BioTools Inc.

Equities

LAB

US34385P1084

Market Closed - Nasdaq
Other stock markets
 21:00:00 10/05/2024 BST 		5-day change 1st Jan Change
2.4 USD -0.41% Intraday chart for Standard BioTools Inc. -4.38% +8.60%
05-08 Transcript : Standard BioTools Inc., Q1 2024 Earnings Call, May 08, 2024
05-08 Earnings Flash (LAB) STANDARD BIOTOOLS Reports Q1 Revenue $45.5M, vs. Street Est of $46M MT

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Earnings Flash (LAB) STANDARD BIOTOOLS Reports Q1 Revenue $45.5M, vs. Street Est of $46M
MT
Standard BioTools Inc. Reaffirms Revenue Guidance for the Fiscal Year 2024
CI
Standard BioTools Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Sector Update: Health Care Stocks Decline Late Afternoon
MT
Sector Update: Health Care
MT
Standard BioTools Initiates Restructuring Plan With 10% Workforce Reduction
MT
Standard BioTools Inc. Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the Boundaries of Tissue Imaging
CI
Sector Update: Health Care Stocks Lean Higher Pre-Bell Thursday
MT
Standard BioTools Enters Into Multi-Year Medicine Research Engagement With Bristol-Myers Squibb
MT
Standard BioTools Inc. Provides Revenue Guidance for the Full Year 2024
CI
Standard BioTools Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Standard BioTools Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Earnings Flash (LAB) STANDARD BIOTOOLS Reports Q4 Revenue $28.2M, vs. Street Est of $24.9M
MT
Standard BioTools Inc. and Next Gen Diagnostics Announce Partnership to Provide Complete Automation of Low-Cost Pathogen Sequencing
CI
Standard Biotools and Navignostics Announce Collaboration Agreement to Advance Imaging Capabilities in Personalized Medicine
CI
Standard Biotools Inc. Provides Revenue Guidance for the Fourth Quarter and full year 2023
CI
Standard BioTools Says Merger With SomaLogic Completed
MT
SomaLogic, Standard BioTools Receive Shareholder Approvals for Pending Merger
MT
Standard BioTools Inc. completed the acquisition of SomaLogic, Inc..
CI
Standard BioTools Inc.'s Equity Buyback announced on November 28, 2022, has expired.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LAB Stock
  4. News Standard BioTools Inc.
  5. Highlights